January 11, 2011
Highly Efficient, Reproducible Non-Cytotoxic Transfection Reagent GenePORTER® Gold from AMSBIO is a new highly efficient and reproducible lipid-based reagent for effective transfection of a wide variety of cell lines. Molecular target delivery faces many barriers, from crossing the cell type-specific extracellular membrane, to cytoplasmic degradation and translocation across the nuclear membrane. To be effective, the [...]
Agilent Technologies Secures Patent for Porous Shell LC Particle Manufacturing Technology
January 11, 2011
Agilent Technologies Inc. (NYSE: A) today announced that it was awarded a U.S. patent for the process used to apply the superficially porous shell to particles in Agilent Poroshell 120 high-performance liquid chromatography (HPLC) columns. The patent was issued for the unique coacervation process used to manufacture the Poroshell 120 silica. The process applies the [...]
Caliper Announces Launch of LabChip(R) Dx for Molecular Diagnostics
January 11, 2011
LabChip Dx Provides Rapid, Accurate and Cost Effective Advanced Nucleic Acid Separations Capability to Clinical Research Laboratories HOPKINTON, Mass. - Caliper Life Sciences, Inc. (Nasdaq: CALP) today announced the launch of Caliper's new, innovative LabChip Dx system for use by clinical research laboratories developing molecular diagnostic tests. The LabChip Dx platform is now available in [...]
January 10, 2011
CAMBRIDGE, Mass. - BioScale Inc., an innovative life science company that develops, manufactures and promotes novel analytical tools enabling advancements in protein research, announced that results from the analysis of two pharmacodynamic biomarkers using the Acoustic Membrane MicroParticles (AMMP™) assay technology on the ViBE Protein Analysis Workstation were published in the peer-reviewed Elsevier Journal of [...]
Polyplus-Transfection Raises EUR 2.5 Million in Latest Funding Round
January 10, 2011
Strasbourg, France - Polyplus-transfection SA, which specializes in the development of innovative solutions for the delivery of nucleic acids in research and therapeutics, announces the completion of a funding round in which it raised EUR 2.5 million. This new round brings in new shareholders in Polyplus-transfection, AIRFI (Alsace Inter Regio Fonds d’Investissement) and Sudinnova, which [...]
Illumina Introduces the Next Generation of iSelect(R) Custom Genotyping
January 10, 2011
Expanded Marker Density and Add-On Content Capabilities Provide Unprecedented Genomic Discovery at Lower Prices SAN DIEGO - Illumina, Inc. (NASDAQ:ILMN) today announced its next generation of iSelect custom genotyping products that allow researchers to design custom arrays containing from 3,000 up to 1,000,000 markers, with the flexibility to add supplemental content to their array designs. [...]
Nexxis iLAB Integrates all Databases
January 10, 2011
Labtronics Inc., a world leader in laboratory automation, is pleased to announce the release of the Nexxis iLAB Database Viewer, a new tool that integrates and simplifies the reporting of data for all lab databases from one central location. The new Nexxis iLAB Database Viewer provides a central location to access data from all of [...]
January 10, 2011
Integromics today announces the publication of a paper in the journal Cell highlighting a novel genome wide profiling of polyadenylation events in human and yeast performed with Direct RNA Sequencing. Granada and Madrid, Spain and Philadelphia, PA, U.S. - Integromics, a market leader in IT solutions provision for life sciences in the field of genomics [...]
Analytik Jena Strengthens Software Division with Corporate Acquisition
January 10, 2011
Jena - Analytik Jena subsidiary AJ Blomesystem GmbH, which specializes in laboratory information management systems (LIMS), has taken acquired 55.0% of the shares in the Hamburg software company comicon GmbH. In particular, comicon develops special software modules in the field of lipid chemistry for laboratory use to supplement the range of products offered by AJ [...]
On-Q-ity Announces Strategic Alliance With LabCorp
January 10, 2011
WALTHAM, Mass. - On-Q-ity, a next-generation oncology diagnostics company developing personalized and predictive tests to improve cancer therapy effectiveness, today announced a strategic alliance with Laboratory Corporation of America Holdings® (LabCorp). LabCorp will market On-Q-ity's novel and proprietary circulating tumor cell (CTC) platform to the biopharma industry to greatly accelerate and improve the cancer drug [...]

